NEW DELHI: A division bench of the Delhi High Court on Monday permitted drugmaker Zydus Lifesciences to sell and market a biosimilar version of the anti-cancer medication Nivolumab in India, setting aside a single judge order that had temporarily restrained the firm from doing the same. The high court allowed Zydus Lifesciences to sell and market a […]
